Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.67M Buy
28,909
+10,775
+59% +$632K 0.03% 261
2017
Q1
$1.08M Sell
18,134
-5,621
-24% -$343K 0.02% 338
2016
Q4
$1.41M Buy
23,755
+15,270
+180% +$854K 0.03% 268
2016
Q3
$420K Buy
+8,485
New +$432K 0.01% 506
2016
Q1
Sell
-5,941
Closed -$239K 732
2015
Q4
$239K Buy
5,941
+7
+0.1% +$288 ﹤0.01% 545
2015
Q3
$223K Sell
5,934
-279
-4% -$12K ﹤0.01% 544
2015
Q2
$274K Buy
+6,213
New +$298K ﹤0.01% 542
2015
Q1
Sell
-6,406
Closed -$314K 723
2014
Q4
$314K Buy
6,406
+4
+0.1% +$208 0.01% 501
2014
Q3
$348K Buy
6,402
+75
+1% +$3.96K 0.01% 489
2014
Q2
$312K Buy
6,327
+24
+0.4% +$1.23K 0.01% 510
2014
Q1
$319K Buy
6,303
+11
+0.2% +$552 0.01% 465
2013
Q4
$336K Buy
6,292
+138
+2% +$7.12K 0.01% 387
2013
Q3
$302K Sell
6,154
-475
-7% -$22.3K 0.01% 392
2013
Q2
$287K Buy
+6,629
New +$294K 0.01% 345

Other funds holding NUE

Geneva Advisors's NUE Position: Q2 2017 in Review

Geneva Advisors increased its Nucor (NUE) stake by 59% in Q2 2017, buying an estimated $632K and bringing the position to 28,909 shares worth $1.67M. The position accounts for 0.03% of the portfolio, ranked #261.

Geneva Advisors first reported a position in NUE in Q2 2013 and has held it in 14 quarters since. 733 funds tracked by Wall St. Rank hold NUE as of Q2 2017.

  • Geneva Advisors held 28,909 shares of Nucor worth $1.67M as of Q2 2017.
  • Geneva Advisors bought 10,775 Nucor shares in Q2 2017, an estimated $632K.
  • Nucor made up 0.03% of Geneva Advisors's portfolio in Q2 2017, its #261 holding.
  • Geneva Advisors first reported a position in Nucor in Q2 2013 and has held it in 14 quarters since.
  • 733 funds tracked by Wall St. Rank held Nucor as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.